Hubei Jumpcan Pharmaceutical Company Overview

  • Founded
  • 1994

Founded
  • Status
  • Public

  • Employees
  • 6,632

Employees
  • Stock Symbol
  • 600566

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $4.46

  • (As of Wednesday Closing)

Hubei Jumpcan Pharmaceutical Company General Information

Description

Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Contact Information

Website
www.jumpcan.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Primary Office
  • Baotawan, Daqing West Road
  • Taixing, Jiangsu 225441
  • China
+86 0523 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hubei Jumpcan Pharmaceutical Company Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.46 $4.40 $2.90 - $4.95 $4.11B 922M 15.7M $0.35

Hubei Jumpcan Pharmaceutical Company Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,039,342 3,237,434 2,262,272 2,610,044
Revenue 1,238,051 1,181,728 892,361 1,004,393
EBITDA 342,487 333,695 248,360 304,396
Net Income 311,121 266,247 184,873 234,885
Total Assets 1,865,592 1,903,176 1,610,105 1,238,372
Total Debt 91,811 98,856 92,953 82,440
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hubei Jumpcan Pharmaceutical Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hubei Jumpcan Pharmaceutical Company‘s full profile, request access.

Request a free trial

Hubei Jumpcan Pharmaceutical Company Executive Team (2)

Name Title Board Seat Contact Info
Longxiang Cao Chief Executive Officer & Chairman
Hongquan Yan Finance Director
To view Hubei Jumpcan Pharmaceutical Company’s complete executive team members history, request access »

Hubei Jumpcan Pharmaceutical Company Board Members (1)

Name Representing Role Since
000000000 000 Hubei Jumpcan Pharmaceutical Company Chief Executive Officer & Chairman 000 0000
To view Hubei Jumpcan Pharmaceutical Company’s complete board members history, request access »

Hubei Jumpcan Pharmaceutical Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hubei Jumpcan Pharmaceutical Company Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 13-Sep-2022 000 000.00 Specialty Retail
To view Hubei Jumpcan Pharmaceutical Company’s complete investments history, request access »